Search research articles
Contact Us
Filters
Showing results (11-20 of 14) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 14 results.
Asian Journal of Andrology
|
February 3, 2005
Morphological characteristics of spermatozoa before and after renal transplantation
Long-Gen Xu, Shi-Fang Shi, Xiao-Ping Qi, et al.
Pharmacology
|
September 29, 2004
Montelukast, a cysteinyl leukotriene receptor-1 antagonist, dose- and time-dependently protects against focal cerebral ischemia in mice
Guo-Liang Yu, Er-Qing Wei, Shi-Hong Zhang, et al.
Frontiers in Neurology
|
May 13, 2022
Human Umbilical Cord Mesenchymal Stem Cells to Treat Neuromyelitis Optica Spectrum Disorder (hUC-MSC-NMOSD): A Study Protocol for a Prospective, Multicenter, Randomized, Placebo-Controlled Clinical Trial
Xiao-Ying Yao, Li Xie, Yu Cai, et al.
Cell Death and Differentiation
|
March 18, 2026
Human umbilical cord mesenchymal stromal cells therapy for neuromyelitis optica spectrum disorder: a phase 1/2a trial
Xiao-Ying Yao, Zhong-Jiao Lu, Nan Zhao, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 14) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 14 results.
Asian Journal of Andrology
|
February 3, 2005
Morphological characteristics of spermatozoa before and after renal transplantation
Long-Gen Xu, Shi-Fang Shi, Xiao-Ping Qi, et al.
Pharmacology
|
September 29, 2004
Montelukast, a cysteinyl leukotriene receptor-1 antagonist, dose- and time-dependently protects against focal cerebral ischemia in mice
Guo-Liang Yu, Er-Qing Wei, Shi-Hong Zhang, et al.
Frontiers in Neurology
|
May 13, 2022
Human Umbilical Cord Mesenchymal Stem Cells to Treat Neuromyelitis Optica Spectrum Disorder (hUC-MSC-NMOSD): A Study Protocol for a Prospective, Multicenter, Randomized, Placebo-Controlled Clinical Trial
Xiao-Ying Yao, Li Xie, Yu Cai, et al.
Cell Death and Differentiation
|
March 18, 2026
Human umbilical cord mesenchymal stromal cells therapy for neuromyelitis optica spectrum disorder: a phase 1/2a trial
Xiao-Ying Yao, Zhong-Jiao Lu, Nan Zhao, et al.
Page
of 2